SMTL ID : 2uzt.1

PKA structures of AKT, indazole-pyridine inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

hetero-1-1-mer

Ligands

1 x SS3: (2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE(Non-covalent)

SS3.1: 18 residues within 4Å: Chain A: L.35, G.36, T.37, V.43, A.56, K.58, V.90, M.106, E.107, Y.108, V.109, E.113, E.156, N.157, L.159, T.169, D.170, F.313 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:L.35, A:L.35, A:V.43, A:V.43, A:A.56, A:V.90, A:M.106, A:E.113, A:L.159, A:T.169, A:F.313, A:F.313, A:F.313 Hydrogen bonds: A:K.58, A:E.107, A:V.109, A:N.157, A:D.170

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhu, G.D. et al., Syntheses of Potent, Selective, and Orally Bioavailable Indazole-Pyridine Series of Protein Kinase B/Akt Inhibitors with Reduced Hypotension. J.Med.Chem. (2007)

Release Date

2007-06-05

Peptides

CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT: A
CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT

CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA

Related Entries With Identical Sequence